secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2025-07-22T23:59:59+00:00
Accession:  0001641172-25-020569
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.03, 3.02, 3.03, 5.03
LLM model:  deepseek-v4-flash:cloud@v2

NanoVibronix raises $8M in private placement of Series H convertible preferred and warrants
--------------------------------------------------------------------------------

- Initial closing of $8M gross proceeds: 8,889 Series H preferred shares ($1,000 stated value, convertible at $1.01/sh) and warrants for 4,678,363 shares at $2.25/sh.
- Second closing of $2.22M (2,222 preferred shares) contingent on customary conditions.
- Net proceeds: $5M to redeem Series X preferred stock; remainder for working capital.
- Investor gets right to buy up to $44M additional preferred stock over 36 months at 85% of average VWAP.
- Company must seek stockholder approval for issuance exceeding 19.99% of outstanding common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000164117225020569/0001641172-25-020569-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000164117225020569/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-020569

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer